The Effect of Alendronate Treatment on Bone Density and Bone Markers in Postmenopausal Osteoporosis
The objective of this blind, randomized controlled study was to evaluate effect of 12 months alendronate treatment on bone mineral density (BMD) and bone formation, resorption markers in postmenopausal osteoporotic women. Women with BMD values at least 2 standard deviations (SD) below BMD of adult p...
Saved in:
| Main Authors: | S. Akı, R. G. Gulbaba, N. Eskiyurt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Publishing House
2002-03-01
|
| Series: | Türk Osteoporoz Dergisi |
| Subjects: | |
| Online Access: | http://www.turkosteoporozdergisi.org/article_4172/The-Effect-Of-Alendronate-Treatment-On-Bone-Density-And-Bone-Markers-In-Postmenopausal-Osteoporosis |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01) -
Periodontal and Biochemical Correlations during Alendronate Treatment in Postmenopausal Women: A Longitudinal Study
by: Aseel Jalil Ibrahim Al-Karawi, et al.
Published: (2025-02-01) -
The relationships between bone turnover markers and bone mineral density in postmenopausal type 2 diabetic women
by: Vadim V. Klimontov, et al.
Published: (2016-11-01) -
Comparison of Effectiveness of Strontium Ranelate and Alendronate Sodium in Postmenopausal Osteoporosis - Original Investigation
by: Kurtuluş Kaya, et al.
Published: (2009-12-01) -
Effects of Teriparatide and Alendronate on Functional Recovery from Spinal Cord Injury and Postinjury Bone Loss
by: Shuai Wang, et al.
Published: (2025-02-01)